Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration.
about
The actin depolymerizing factor (ADF)/cofilin signaling pathway and DNA damage responses in cancerRecent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsSecondary metabolism in Penicillium expansum: Emphasis on recent advances in patulin research.Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B.
P2860
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Chemotherapy in vivo against M ...... and liposomal administration.
@en
Chemotherapy in vivo against M ...... and liposomal administration.
@nl
type
label
Chemotherapy in vivo against M ...... and liposomal administration.
@en
Chemotherapy in vivo against M ...... and liposomal administration.
@nl
prefLabel
Chemotherapy in vivo against M ...... and liposomal administration.
@en
Chemotherapy in vivo against M ...... and liposomal administration.
@nl
P2093
P2860
P1476
Chemotherapy in vivo against M ...... and liposomal administration.
@en
P2093
Christine M Corsette
Christopher Acquafondata
Joan M Mitchell
Thomas P Fondy
P2860
P2888
P304
P356
10.1007/S10637-014-0202-6
P577
2015-01-06T00:00:00Z